Woodline Partners LP

Position in EYPT — EyePoint, Inc.

CIK 1784547 San Francisco, CA

Position in EYPT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,294,968

-$540,491 QoQ

Shares Held

100,463

0.0% QoQ

Ownership

0.120%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. EYPT ranks #164 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,294,968	100,463	0.0%	Shares	Sole	2026-05-15
2025-12-31	$1,835,459	100,463	+0.2%	Shares	Sole	2026-02-17
2025-09-30	$1,427,745	100,263	-80.0%	Shares	Sole	2025-11-14
2025-06-30	$4,708,152	500,335	0.0%	Shares	Sole	2025-08-14
2025-03-31	$2,711,815	500,335	-0.3%	Shares	Sole	2025-05-15
2024-12-31	$3,737,843	501,724	+25.4%	Shares	Sole	2025-02-14
2024-09-30	$3,196,000	400,000	-16.6%	Shares	Sole	2024-11-14
2024-03-31	$9,915,026	479,682	+19.9%	Shares	Sole	2024-05-15
2023-12-31	$9,244,000	400,000	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.